@article{b67f58f352004a8e87dc4743327c8469,
title = "Title X Improved Access To Most Effective And Moderately Effective Contraception In US Safety-Net Clinics, 2016–18",
abstract = "Community health centers are a crucial source of health care for reproductive-age women. Some community health centers receive funding from the federal Title X program, which provides funding for family planning services for low-income women. We describe the provision of the most effective (intrauterine devices and implants) and moderately effective (short-acting hormonal methods) contraceptive methods in a large network of 384 community health center clinics across twenty states in 2016–18. Title X clinics provided more most and moderately effective contraception at all time points and for all age groups (adolescent, young adult, and adult). They provided 52 percent more of the most effective contraceptives to women at risk for pregnancy than clinics not funded by Title X. This finding was especially notable for adolescents (58 percent more). Title X clinics play a key role in access to effective contraception across the US safety net. Strengthening the Title X program should continue to be a policy priority for public health for the Biden-Harris administration.",
author = "Darney, {Blair G.} and Biel, {Frances M.} and Megan Hoopes and Rodriguez, {Maria I.} and Brigit Hatch and Miguel Marino and Anna Templeton and Jee Oakley and Teresa Schmidt and Cottrell, {Erika K.}",
note = "Funding Information: This study was funded by the Office of Population Affairs (OPA) (1 FPRPA006071-01-00; Blair Darney, principal investigator). Additional funding was provided by the Agency for Healthcare Research and Quality (AHRQ) (1R01HS025155-01; Erika Cottrell, principal investigator). This work was conducted with the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) Clinical Research Network (CRN). ADVANCE is a CRN in PCORnet, the National Patient Centered Outcomes Research Network. ADVANCE is led by OCHIN in partnership with Health Choice Network, Fenway Health, and Oregon Health & Science University. ADVANCE{\textquoteright}s participation in PCORnet is funded through the Patient-Centered Outcomes Research Institute (PCORI), Contract No. RI-OCHIN-01-MC. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Preliminary findings were presented at the 48th Annual Meeting of the North American Primary Care Research Group (virtual), November 20–24, 2020; Population Association of America, 2021 Annual Meeting (virtual), May 5–8, 2021; and Title X Grantee Conference (virtual), July 13–16, 2021. Darney{\textquoteright}s institution receives research support from Merck/ Organon. Darney also serves on the board of directors of the Society of Family Planning. Maria Rodriguez has served as a contraceptive trainer for Merck and the American Congress of Obstetricians and Gynecologists. She has served on an advisory board for Bayer and as a consultant for the World Health Organization. Her institution has received research funding from Arnold Ventures, the National Institutes of Health, Merck, and the Robert Wood Johnson Foundation on projects where she is the primary investigator. These potential conflicts of interest for Rodriguez have been reviewed and managed by Oregon Health & Science University. Publisher Copyright: {\textcopyright} 2022, Project HOPE. All rights reserved.",
year = "2022",
month = apr,
doi = "10.1377/hlthaff.2021.01483",
language = "English (US)",
volume = "41",
pages = "497--506",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "4",
}